{
    "clinical_study": {
        "@rank": "156214", 
        "acronym": "H-pylori", 
        "arm_group": [
            {
                "arm_group_label": "azithromycin", 
                "arm_group_type": "Experimental", 
                "description": "Azithromycin (Zithromax, Azithrocin ) is an azalide, a subclass of macrolide antibiotics. Azithromycin is one of the world's best-selling antibiotics. It is derived from erythromycin, with a methyl-substituted nitrogen atom incorporated into the lactone ring, thus making the lactone ring 15-membered."
            }, 
            {
                "arm_group_label": "clarithromycin", 
                "arm_group_type": "Experimental", 
                "description": "Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydophila pneumoniae), skin and skin structure infections. In addition, it is sometimes used to treat legionellosis, Helicobacter pylori, and lyme disease."
            }
        ], 
        "brief_summary": {
            "textblock": "The  Aim  of  this  study  is  comparison  between  two  regimens  containing\n      clarithromycinand   azithromycin."
        }, 
        "brief_title": "Aizthromycin or Clarithromycin in H-pylori Eradication Regimen", 
        "completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Peptic Ulcer", 
            "Dyspepsia", 
            "H-pylori"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Dyspepsia", 
                "Peptic Ulcer", 
                "Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "Eradication of helicobacter pylori   is  important  for  treatment  of  GU  but  ideal\n      regimen  is  not  available.\n\n      HP  is  resistant  to  metronidazole and  clarithromycin, thus  clarithromycin  is\n      expensive   and   it  is  not  available  in  underdevelopment  countries.\n\n      There  are  different  articles  about   replacement clarithromycin with azithromycin  as  a\n       method  of  eradication of  HP  that  is  decreases  length     of  therapy  and\n      increases, effectiveness  of  drugs  and  decreases  resistance  of  drugs.\n\n      The  Aim  of  this  study  is  comparison  between  two  regimens  containing\n      clarithromycinand   azithromycin."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with peptic ulcer due to H-pylori confirmed endoscopy and biopsy\n\n        Exclusion Criteria:\n\n          -  patients who got H-pylori eradication treatment previously\n\n          -  patients who used study drugs during 3months before study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "78", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01667692", 
            "org_study_id": "ssu.hakimi-89027"
        }, 
        "intervention": [
            {
                "arm_group_label": "azithromycin", 
                "description": "Azithromycin (Zithromax, Azithrocin ) is an azalide, a subclass of macrolide antibiotics. Azithromycin is one of the world's best-selling antibiotics.[1] It is derived from erythromycin, with a methyl-substituted nitrogen atom incorporated into the lactone ring, thus making the lactone ring 15-membered.", 
                "intervention_name": "azithromycin", 
                "intervention_type": "Drug", 
                "other_name": "(Zithromax, Azithrocin"
            }, 
            {
                "arm_group_label": "clarithromycin", 
                "description": "Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydophila pneumoniae), skin and skin structure infections. In addition, it is sometimes used to treat legionellosis, Helicobacter pylori, and lyme disease.", 
                "intervention_name": "clarithmycin", 
                "intervention_type": "Drug", 
                "other_name": "Crixan, Claritt, Clarac, Biaxin, Klaricid, Klacid..."
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Azithromycin", 
                "Clarithromycin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "H-pylori", 
            "eradication", 
            "azithromycin", 
            "clarithromycin"
        ], 
        "lastchanged_date": "August 15, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Yazd", 
                    "country": "Iran, Islamic Republic of", 
                    "zip": "8916863411"
                }, 
                "name": "Behnam Baghianimoghadam"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Azithromycin or Clarithromycin in 3drugs Protocol of H-pylori Eradication Regimen", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ministry of health and medical education", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "confirmation is by endoscopy and biopsy", 
            "measure": "H-pylori cinfirmation", 
            "safety_issue": "Yes", 
            "time_frame": "1-3 months before study"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01667692"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shahid Sadoughi University of Medical Sciences and Health Services", 
            "investigator_full_name": "Behnam Baghianimoghadam", 
            "investigator_title": "research consultant", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "confirmation of eradication was by endoscopy and biopsy", 
                "measure": "h-pylori eradication confirmation", 
                "safety_issue": "Yes", 
                "time_frame": "two months after completion of 14 days standard treatment"
            }, 
            {
                "description": "it was assessed by researcher and self report of patients. variables like nausea, vomiting and diarrhea. the prevalence of each treatment related complain was registered by taking history from patients.", 
                "measure": "side effect of study srugs", 
                "safety_issue": "Yes", 
                "time_frame": "during 14 days standard treatment"
            }
        ], 
        "source": "Shahid Sadoughi University of Medical Sciences and Health Services", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shahid Sadoughi University of Medical Sciences and Health Services", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}